InvestorsHub Logo
Followers 25
Posts 2057
Boards Moderated 0
Alias Born 12/18/2012

Re: None

Friday, 04/21/2017 7:20:00 AM

Friday, April 21, 2017 7:20:00 AM

Post# of 17462
Glickman put AUPH on the map yesterday! The superb "48-week results from its global Phase IIb AURA-LV (AURA) study in lupus nephritis (LN) during the National Kidney Foundation 2017 Spring Clinical Meetings in Orlando, FL.", have I believe set the stage for a very likely BO perhaps even before Phase III is completed. The National Kidney Foundation Spring meeting was the perfect storm in which to release the data. It is exciting to be, in a small part, involved in the development of a drug with such enormous potential to transform the lives of those suffering from lupus nephritis. Exciting days ahead!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News